Il y a eu 23 transactions d'initiés récentes enregistrées pour Bellevue Life Sciences Acquisition Corp. (BLAC), dont 6 achats et 9 ventes. Le total des achats d'initiés s'élève à $690K et le total des ventes d'initiés à $920K.
Les initiés notables ayant une activité récente comprennent Kim Sang Hyun, Lee Phil Geon, Yoo David Jin. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — BLAC
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2024-06-23 |
Kim Sang Hyun |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-05-27 |
Lee Phil Geon |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-03-23 |
Yoo David Jin |
Chief Financial Officer |
Attribution de RSU |
20,000 |
$11.50 |
$230K |
20,000 |
| 2023-03-23 |
Hwang Kuk Hyoun |
10 Percent Owner, Officer: Chief Executive Officer |
Autre (Vente) |
20,000 |
$11.50 |
$230K |
370,000 |
| 2023-03-23 |
Bellevue Global Life Science Investors Llc |
10 Percent Owner |
Autre (Vente) |
20,000 |
$11.50 |
$230K |
370,000 |
| 2023-02-21 |
Hwang Kuk Hyoun |
10 Percent Owner, Officer: Chief Executive Officer |
Autre (Vente) |
4,500 |
- |
- |
2,020,500 |
| 2023-02-21 |
Bellevue Global Life Science Investors Llc |
10 Percent Owner |
Autre (Vente) |
4,500 |
- |
- |
2,020,500 |
| 2023-02-14 |
Reed Steven |
Director |
Attribution de RSU |
20,000 |
$11.50 |
$230K |
20,000 |
| 2023-02-14 |
Hwang Kuk Hyoun |
10 Percent Owner, Officer: Chief Executive Officer |
Autre (Vente) |
20,000 |
$11.50 |
$230K |
390,000 |
| 2023-02-14 |
Chung In Chul |
Director |
Attribution de RSU |
20,000 |
$11.50 |
$230K |
20,000 |
| 2023-02-14 |
Euh Hosun |
Director |
Attribution de RSU |
20,000 |
- |
- |
20,000 |
| 2023-02-14 |
Park Jin Whan |
Director |
Attribution de RSU |
20,000 |
- |
- |
20,000 |
| 2023-02-14 |
Roberts Rad |
Director |
Attribution de RSU |
20,000 |
- |
- |
20,000 |
| 2023-02-14 |
Bellevue Global Life Science Investors Llc |
10 Percent Owner |
Autre (Vente) |
20,000 |
$11.50 |
$230K |
390,000 |
| 2023-02-09 |
Reed Steven |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-02-09 |
Yoo David Jin |
Chief Financial Officer |
Cession |
- |
- |
- |
- |
| 2023-02-09 |
Hwang Kuk Hyoun |
10 Percent Owner, Officer: See Remarks |
Inconnu |
- |
- |
- |
1,725,000 |
| 2023-02-09 |
Chung In Chul |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-02-09 |
Euh Hosun |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-02-09 |
Park Jin Whan |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-02-09 |
Whang Jun Chul |
Director |
Cession |
- |
- |
- |
- |
| 2023-02-09 |
Roberts Rad |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-02-09 |
Bellevue Global Life Science Investors Llc |
10 Percent Owner |
Cession |
- |
- |
- |
1,725,000 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi